Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prevalence of TTR-CA in Aortic Stenosis
NCT04899180Phase 1Completed
- Sponsor
- Mayo Clinic
- Start
- Jul 2023
- Primary completion
- Jan 2024
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial, sponsored by Mayo Clinic. Primary endpoint: Prevalence of Transthyretin Cardiac Amyloidosis. Started Jul 2023; status: completed.
Beyond the preview
Go deeper on NCT04899180.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04899180.